Commentary on "Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data"
Overview
Overview
Journal
Oncologist
Publisher
Oxford University Press
Specialty
Oncology
Date
2017 Jul 29
PMID
28751507
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion.
Abdulla M, Belal A, Sakr A, El Arab L, Mokhtar M, Allahloubi N Health Sci Rep. 2023; 6(1):e1037.
PMID: 36698712 PMC: 9847398. DOI: 10.1002/hsr2.1037.
Panihar C, Rawat S, Singotia L, Raj A, Jain R Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):2670-2675.
PMID: 36452529 PMC: 9702380. DOI: 10.1007/s12070-020-02350-6.